Actively Recruiting
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Led by Vanderbilt-Ingram Cancer Center · Updated on 2025-09-19
2100
Participants Needed
1
Research Sites
365 weeks
Total Duration
On this page
Sponsors
V
Vanderbilt-Ingram Cancer Center
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the impact that a sarcoma diagnosis and treatment have had on patients over time.
CONDITIONS
Official Title
Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of any age with a history of sarcoma, regardless of current disease status
- For pediatric patients, participation includes parent or primary caregiver of the patient
- Siblings of pediatric patients aged 8 years or older
You will not qualify if you...
- None explicitly stated in the eligibility criteria
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Vanderbilt University/Ingram Cancer Center
Nashville, Tennessee, United States, 37203
Actively Recruiting
Research Team
V
Vanderbilt-Ingram Services for Timely Access
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here